The effect of rs1421085 polymorphism of FTO gene on progress of hypertension in overweight and obese subjects
 
More details
Hide details
1
Katedra Chorób Wewnętrznych, Diabetologii i Nefrologii Wydziału Lekarskiego z Oddziałem Lekarsko-Dentystycznym w Zabrzu Śląskiego Uniwersytetu Medycznego w Katowicach
 
 
Corresponding author
Władysław Grzeszczak   

Katedra Chorób Wewnętrznych, Diabetologii i Nefrologii Wydziału Lekarskiego z Oddziałem Lekarsko-Dentystycznym w Zabrzu Śląskiego Uniwersytetu Medycznego w Katowicach, ul. 3 Maja 13/15, 41-800 Zabrze, tel. +48 32 370 44 14,
 
 
Ann. Acad. Med. Siles. 2016;70:51-55
 
KEYWORDS
TOPICS
ABSTRACT
Aim:
The aim of the study was to demonstrate the potential association between the rs1421085 polymorphism of the FTO gene and the incidence of hypertension and overweight and obesity in consecutive patients reporting to a primary care physician in a Public Health Centre.

Materials and methods:
The study included a total of 391 patients from the area of southern Poland, who in turn reported to the Public Health Centre. The patients were divided into 3 groups based on their waist circumference score (control group, group of overweight patients and obese patients). Genotyping was carried out using a fluorescently labeled probe and readily prepared single nucleotide polymorphism kits – TaqMan Pre-designed SNP Genotyping Assay (Applied Biosystems). For statistical analysis we used the Statistica 9.0 program.

Results:
The prevalence of overweight and obesity judged by the waist circumference score was 71.35%, for 24.04% of which constituted overweight people and 47.31% the obese. In the serum of overweight and obese people statistically significant higher levels of glucose concentration, insulin, mean arterial pressure and lipid profile components were found in comparison to the people from the control group (p < 0.001). In the control group no genotype showed a correlation with a higher average systolic pressure – statistically expressed as p ≥ 0.05. In the overweight and obese groups, homozygotes for the T allele exhibit a higher average systolic pressure than the other genotypes (p < 0.05).

Conclusions:
1. Polymorphism rs1421085 of the FTO gene does not show a statistically significant correlation with the prevalence of overweight and obesity in the population of southern Poland. 2. The probability of exhibiting hypertension in a person who is a TT homozygote within the rs1421085 polymorphism is statistically significantly higher than in other genotypes, in overweight or obese subjects.

REFERENCES (7)
1.
Hypertension: uncontrolled and conquering the world. Lancet 2007; 370(9587): 539.
 
2.
Zdrojewski T., Szpakowski P., Bandosz P., Szpakowski P., Konarski R., Jakubowski Z., Manikowski A., Wołkiewicz E., Łysiak-Szydłowska W., Bautembach S., Wyrzykowski B. Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL PLUS. Kardiol. Pol. 2004; 61 (supl. 4): 1–26.
 
3.
Rutkowski M., Bandosz P., Czupryniak L., Gaciong Z., Solnica B., Jasiel-Wojculewicz H., Wyrzykowski B., Pencina M.J., Zdrojewski T. Prevalence of diabetes and impaired fasting glucose in Poland-the NATPOL 2011 Study. Diabet Med. 2014; 31(12): 1568–1571.
 
4.
Hall J.E. Pathophysiology of obesity hypertension. Curr. Hypertens. Rep. 2000; 2(2): 139–147.
 
5.
Reaven G.M., Lithell H., Landsberg L. Hypertension and associated metabolic abnormalities – the role of insulin resistance and the sympathoadrenal system. N. Engl. J. Med. 1996; 334: 374–381.
 
6.
Scuteri A., Sanna S., Chen W., Uda M., Albai G., Strait J., Najjar S., Nagaraja R., Orru M., Usala G., Dei M., Lai S., Maschio A., Busonero F., Mulas A., Ehret G., Fink A., Weder A., Cooper R., Galan P., Chakravarti A., Schlessinger D., Cao A., Lakatta A., Abecasis G. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PloS Genet. 2007; 3(7): e115.
 
7.
He D., Fu M., Miao S., Hotta K., Chandak GR., Xi B. FTO gene variant and risk of hypertension: a meta-analysis of 57,464 hypertensive cases and 41,256 controls. Metabolism 2014; 63(5): 633–639.
 
eISSN:1734-025X
Journals System - logo
Scroll to top